Neurological diseases are diseases caused by a variety of causes, which occur in the central nervous system, the peripheral nervous system, and the autonomic nervous system, which are mainly manifested by sensory, motor, consciousness, and autonomic dysfunction, and seriously affect human health. The research fields of neurological diseases include neurodegenerative diseases, cerebrovascular diseases, dyskinesias, central nervous system demyelinating diseases, epilepsy, genetic metabolic diseases, neuromuscular diseases, infections, tumors, etc. The main research contents involve neurological diseases. Etiology, pathogenesis, pathology, clinical manifestations, diagnostic marker studies, drug target screening and treatment. With the in-depth study of the pathogenesis of neurological diseases, it provides theoretical and experimental basis for its gene therapy strategy. In addition, stem cell transplantation replacement therapy provides a new way for the treatment of neurological diseases.

In recent years, non-coding RNA has become a research hotspot of the nervous system. lncRNA and miRNA have been widely involved in the pathophysiological process of human neurological diseases and play an important role. Therefore, by studying the relationship between non-coding RNA and neurological diseases, it is expected to elucidate the pathogenesis of neurological diseases and find potential therapeutic targets.

RiboBio provides a complete solution for lncRNA/miRNA research. Covers a series of products and services such as differential expression screening, expression verification, cell function research, mechanism research, animal experiments.